Dioxoacetildenafil |
|
| Synonyms: Dioxohongdenafil; 1-(2-(4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl)-2-oxoethyl)-4-ethylpiperazine-2,3-dione | |
| Cat. No.: A01012 | CAS No.: N.A. |
| MDL.: | Formula: C25H30N6O5 |
| F.W.494.54 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | A01012 | CAS No.: | N.A. | |
| MDL: | Formula: | C25H30N6O5 | ||
| F.W.: | 494.54 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Off-White Solid | M.P.: | ||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO, Methanol | Stability: | ||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Brock, G., et al.: Drugs Today, 36, 125 (2000); Rosen, R., et al.: Am. J. Cardiol., 92, 9 (2003); Shimizu-Albergine, M., et al.: J. Neurosci., 23, 6452 (2003); Venhuis, B.J., et al.: Forensic Sci. International., 177, 25 (2008) | |||
| Application: | Dioxoacetildenafil is a derivative of Acetildenafil , a designer drug which acts as a phosphodiesterase inhibitor. | |||
| Category: | Nucleotides, Bases & Related Reagents, Intermediates | |||








